Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification

References

• Zheng ZJ, Croft JB, Giles WH, MensahGA. Sudden cardiac death in the United States, 1989 to 1998. Circulation104(18), 2158–2163 (2001).
   PubMed Web of Science ®Google Scholar
• Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J. Cardiovasc. Electrophysiol.12(3), 369–381(2001).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237(2005).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
   PubMed Web of Science ®Google Scholar
• Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation69(2), 250–258 (1984).
   PubMed Web of Science ®Google Scholar
• Mukharji J, Rude RE, Poole WK et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am. J. Cardiol.54(1), 31–36 (1984).
   PubMed Web of Science ®Google Scholar
• Stecker EC, Vickers C, Waltz J et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J. Am. Coll. Cardiol.47(6), 1161–1166 (2006).
   PubMed Web of Science ®Google Scholar
• Every N, Hallstrom A, McDonald KM et al. Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am. Heart J.144(3), 390–396 (2002).
   PubMed Web of Science ®Google Scholar
• Zimetbaum PJ. A 59-year-old man considering implantation of a cardiac defibrillator. JAMA297(17),1909–1916 (2007).
   PubMedGoogle Scholar
• Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA298(13),1525–1532 (2007).
   PubMed Web of Science ®Google Scholar
• Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med.353(14),1471–1480 (2005).
   PubMed Web of Science ®Google Scholar
• Mushlin AI, Hall WJ, Zwanziger J et al. The cost–effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation97(21), 2129–2135 (1998).
   PubMed Web of Science ®Google Scholar
• Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J. Am. Coll. Cardiol.46(1), 75–82 (2005).
   PubMed Web of Science ®Google Scholar
• Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias. J. Am. Coll. Cardiol.47(2), 269–281 (2006).
   PubMed Web of Science ®Google Scholar
• Hering HE. Experimentelle Studie an Säugetieren über das Elektrokardiogramm. Zeitschrift f.exp. Pathologie u.Therapie.7, 363–378 (1909).
   Google Scholar
• Schwartz PJ, Malliani A.Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q–T syndrome. Am. Heart J.89(1), 45–50 (1975).
   PubMed Web of Science ®Google Scholar
• Puletti M, Curione M, Righetti G, Jacobellis G. Alternans of the ST segment and T wave in acute myocardial infarction. J. Electrocardiol.13(3), 297–300 (1980).
   PubMedGoogle Scholar
• Joyal M, Feldman RL, Pepine CJ. ST-segment alternans during percutaneous transluminal coronary angioplasty. Am. J. Cardiol.54(7), 915–916 (1984).
   PubMedGoogle Scholar
• Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. Effect of heart rate on T wave alternans. J. Cardiovasc. Electrophysiol.9(7), 703–708 (1998).
   PubMedGoogle Scholar
• Kaufman ES, Mackall JA, Julka B, Drabek C, Rosenbaum DS. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am. J. Physiol. Heart Circ. Physiol.279(3), H1248–H1255 (2000).
   Google Scholar
• Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J. Cardiovasc. Electrophysiol.13(5), 502–512 (2002).
   PubMedGoogle Scholar
• Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfalls. J. Cardiovasc. Electrophysiol.7(11), 1095–111 (1996).
   PubMedGoogle Scholar
• Hohnloser SH, Klingenheben T, Zabel M, Li YG, Albrecht P, Cohen RJ. T wave alternans during exercise and atrial pacing in humans. J. Cardiovasc. Electrophysiol.8(9), 987–993 (1997).
   PubMedGoogle Scholar
• Rashba EJ, Osman AF, MacMurdy K et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J. Cardiovasc. Electrophysiol.13(9), 845–850 (2002).
   PubMedGoogle Scholar
• Bloomfield DM, Ritvo BS, Parides MK, Kim MH. The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin. Electrophysiol.25(8), 1185–1191 (2002).
   PubMedGoogle Scholar
• Molon G, Costa A, Bertolini L et al. Relationship between abnormal microvolt T wave alternans and poor glycemic control in Type-2 diabetic patients. Pacing Clin. Electrophysiol.30(10), 1267–1272 (2007).
   PubMedGoogle Scholar
• Rashba EJ, Osman AF, MacMurdy K et al. Influence of QRS duration on the prognostic value of T wave alternans. J. Cardiovasc. Electrophysiol.13(8), 770–775 (2002).
   PubMedGoogle Scholar
• Kaufman ES, Bloomfield DM, Steinman RC et al. ‘Indeterminate’ microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.48(7), 1399–1404 (2006).
   PubMedGoogle Scholar
• Chan PS, Bartone C, Booth T, Kereiakes D, Chow T. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am. Heart J.153(4), 523–529 (2007).
   PubMedGoogle Scholar
• Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J. Appl. Physiol.92(2), 541–549 (2002).
   PubMedGoogle Scholar
• Exner DV, Kavanagh KM, Slawnych MP et al. Noninvasive Risk Assessment Early After a Myocardial Infarction - The REFINE Study. J. Am. Coll. Cardiol.50(24), 2275–2284 (2007).
   PubMed Web of Science ®Google Scholar
• Nieminen T, Lehtimaki T, Viik J et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur. Heart J.28(19), 2332–2337 (2007).
   PubMedGoogle Scholar
• Rashba EJ, Cooklin M, MacMurdy K et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation105(7), 837–842 (2002).
   PubMedGoogle Scholar
• Klingenheben T, Gronefeld G, Li YG, Hohnloser SH. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J. Am. Coll. Cardiol.38(7), 2013–2019 (2001).
   PubMedGoogle Scholar
• Kop WJ, Krantz DS, Nearing BD et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation109(15), 1864–1869 (2004).
   PubMedGoogle Scholar
• Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation106(14), 1800–1805 (2002).
   PubMed Web of Science ®Google Scholar
• Verrier RL, Nearing BD, La Rovere MT et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J. Cardiovasc. Electrophysiol.14(7), 705–711(2003).
   PubMedGoogle Scholar
• Muller JE. Circadian variation in cardiovascular events. Am. J. Hypertens.12(2 Pt 2), 35S–42S(1999).
   Web of Science ®Google Scholar
• Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical Alternans and Vulnerability to Ventricular Arrhythmias. N. Engl. J. Med.330(4), 235–241 (1994).
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, DiCarlo L et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med.342(26), 1937–1945 (2000).
   PubMed Web of Science ®Google Scholar
• Ikeda T, Sakata T, Takami M et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J. Am. Coll. Cardiol.35(3), 722–730 (2000).
   PubMed Web of Science ®Google Scholar
• Klingenheben T, Zabel M, D’Agostino RB, Cohen RJ, Hohnloser SH. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet356(9230), 651–652 (2000).
   PubMedGoogle Scholar
• Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet362(9378), 125–126 (2003).
   PubMed Web of Science ®Google Scholar
• Bloomfield DM, Steinman RC, Namerow PB et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation110(14), 1885–1889 (2004).
   PubMedGoogle Scholar
• Costantini O, Rosenbaum DS. ABCD (Alternans Before Cardioverter Defibrillator). Clin. Cardiol.30, 97–100 (2007).
   Google Scholar
• Bloomfield DM, Bigger JT, Steinman RC et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.47(2), 456–463 (2006).
   PubMedGoogle Scholar
• Chow T, Kereiakes DJ, Bartone C et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J. Am. Coll. Cardiol.47(9), 1820–1827 (2006).
   PubMedGoogle Scholar
• Chow T, Kereiakes DJ, Bartone C et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J. Am. Coll. Cardiol.49(1), 50–89 (2007).
   PubMed Web of Science ®Google Scholar
• Chan PS, Stein K, Chow T et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J. Am. Coll. Cardiol.48(1), 112–121 (2006).
   PubMedGoogle Scholar
• Cantillon D, Stein KM, Markowitz SM et al. Predictive value of microvolt T wave alternans in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.50, 166–173 (2007).
   PubMedGoogle Scholar
• Salerno-Uriarte JA, De Ferrari GM, Klersy C et al. Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study. J. Am. Coll. Cardiol.50(19), 1896–1904 (2007).
   PubMedGoogle Scholar
• Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation108(23), 2883–2891 (2003).
   PubMed Web of Science ®Google Scholar
• Gold MR, Ensley D, Chilson D et al. T-wave alternans SCD-HeFT study: primary events analysis (abstract). Ciculation114(Suppl. II), 428–429 (2006).
   Google Scholar
• Chow T, Kereiakes DJ, Onufer J et al. Primary results from the microvolt T wave alternans testing for risk stratification of post MI patients (MASTER I) Trial (abstract). Ciculation116(22), 2631 (2007).
   Google Scholar
• Ellenbogen KA, Levine JH, Berger RD et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ciculation113(6), 776–782 (2006).
   PubMed Web of Science ®Google Scholar
• Connolly SJ. Use and misuse of surrogate outcomes in arrhythmia trials. Circulation113(6), 764–766 (2006).
   PubMedGoogle Scholar
• Walker ML, Rosenbaum DS. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc. Res.57(3), 599–614 (2003).
   PubMed Web of Science ®Google Scholar
• Rashba EJ, Osman AF, MacMurdy K et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J. Cardiovasc. Electrophysiol.15(2), 170–176 (2004).
   PubMedGoogle Scholar
• Ikeda T, Yoshino H, Suqi K et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. J. Am. Coll. Cardiol.48(11), 2268–2274 (2006).
   PubMedGoogle Scholar
• Exner DV, Kavanagh KM, Slawnych MP et al. Non-invasive risk assessment early after a myocardial infarction the REFINE study. J. Am. Coll. Cardiol.50(24), 2275–2284 (2007).
   PubMed Web of Science ®Google Scholar
• Hohnloser S. Oral Abstract Presentation. HRS Scientific Sessions (2008).
   Google Scholar
• Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J. Am. Coll. Cardiol.50(7), 614–622 (2007).
   PubMedGoogle Scholar
• Bigger JT, Kleiger RE. Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary. Am. J. Cardiol.98(9), 1291–1293 (2006).
   PubMedGoogle Scholar
• Personal communications – Marketing and research division, Medtronic Inc. (2008).
   Google Scholar